Pfizer revives weight-loss medication
Pfizer is planning clinical studies for danuglipron, a once-daily weight-loss medication, after discontinuing the twice-daily version
Most Read
-
Gold price in Pakistan sees fifth consecutive increase
-
Internet, broadband services to be blocked
-
Punjab to convert all old motorcycles into electric bikes
-
Govt reduces Hajj airfares massively for 2025
-
All major Karachi roads closed over 'security concerns'
-
Saudi Riyal to PKR latest rate today – 23 Nov 2024
-
Karachi board Intermediate Part II results announced
-
All motorways to be closed from tonight
-
All entry and exit points of Islamabad to be sealed, transport shut
-
Household water waste: Rs20,000 fine on washing cars, floors with pipes
-
